Viewing Study NCT05215912


Ignite Creation Date: 2025-12-26 @ 10:16 PM
Ignite Modification Date: 2025-12-26 @ 10:16 PM
Study NCT ID: NCT05215912
Status: COMPLETED
Last Update Posted: 2024-03-20
First Post: 2021-11-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers
Sponsor: TeneoFour Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-04-21
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-04
Primary Completion Date Type: ACTUAL
Completion Date: 2023-07-11
Completion Date Type: ACTUAL
First Submit Date: 2021-11-23
First Submit QC Date: None
Study First Post Date: 2022-01-31
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-19
Last Update Post Date: 2024-03-20
Last Update Post Date Type: ACTUAL